cancer clinical trials in lansing, MI
Sparrow Hospital
Lansing, Michigan 48912 Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Esophageal Cancer
|
Sparrow Regional Cancer Center
Trial Locations Sparrow Regional Cancer Center Breslin Cancer Center at Ingham Regional Medical Center Breast Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Multiple Myeloma and Plasma Cell Neoplasm
|
Sparrow Regional Cancer Center
Trial Locations Sparrow Regional Cancer Center Breslin Cancer Center at Ingham Regional Medical Center Breast Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Prostate Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Small Intestine Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lung Cancer
|
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan 48910 Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
|
Investigational Site
Lansing, Michigan 48912 Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Neoplasms
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lung Cancer
|
Sparrow Regional Cancer Center
Trial Locations Sparrow Regional Cancer Center Breslin Cancer Center at Ingham Regional Medical Center Lung Cancer
|
Sparrow Regional Cancer Center
Trial Locations Sparrow Regional Cancer Center Breslin Cancer Center at Ingham Regional Medical Center Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lung Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
|
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan 48910 Neuroblastoma
|
Breslin Cancer Center / Great Lakes Cancer Institute
Lansing, Michigan 48910 Multiple Myeloma
|
CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute
Lansing, Michigan 48910 Idiopathic Thrombocytopenic Purpura
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Leukemia
|
Sparrow Hospital
Lansing, Michigan 48912 HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Leukemia
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Brain and Central Nervous System Tumors
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lung Cancer
|
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan 48910 Leukemia
|
Sparrow Hospital
Lansing, Michigan 48912 Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan 48910 Neuroblastoma
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Prostate Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 Neuroendocrine Carcinoma
|
Sparrow Hospital
Lansing, Michigan 48912 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
Ingham Regional Medical Center
Trial Locations Ingham Regional Medical Center Sparrow Hospital Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lung Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
Sparrow Hospital
Lansing, Michigan 48912 Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lung Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Michigan State University / Breslin Cancer Center Breslin Cancer Center
Lansing, Michigan Myelogenous Leukemia, Chronic
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
|
Sparrow Hospital
Lansing, Michigan 48912 Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
Sparrow Hospital
Lansing, Michigan 48912 Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Malignant Mesothelioma
|
Sparrow Regional Cancer Center
Trial Locations Sparrow Regional Cancer Center Breslin Cancer Center at Ingham Regional Medical Center Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
|
Sparrow Hospital
Lansing, Michigan 48912 Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Tumor, Ovarian Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Lymphoma
|
Sparrow Hospital
Lansing, Michigan 48912 Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
|
Sparrow Hospital
Lansing, Michigan 48912 Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Leukemia
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Ovarian Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Breast Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
|
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan 48910 Leukemia
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Liver Cancer
|
Sparrow Regional Cancer Center
Lansing, Michigan 48912-1811 Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
|
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan 48910 Leukemia, Lymphoma
|